// App-Quantinova.ai

4805 : Minimal Residual Disease in Adults with Advanced Relapsed Philadelphia Chromosome Negative Acute Lymphoblastic Leukemia Treated with Marqibo (vinCRIStine sulfate LIPOSOME injection)

Researchers

Presenter

  • Olivia R. Deitcher

Principal Investigators

  • Stuart L. Goldberg

  • Wendy Stock

  • Gary J. Schiller

  • John Lister

  • Jeffrey A. Silverman

  • Steven R. Deitcher

  • Susan O'Brien

Medical Centers

  • University of California, Los Angeles, Los Angeles, CA

Locations

  • United States

Companies

  • Talon Therapeutics,

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Ph chromosome

Drug/Treatment

  • Vincristine

Outcome

  • N/A

Study Design

  • double blind/blinded

Phase

  • II

Study Id's

  • NCT00495079

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved